OpenAI has introduced ChatGPT Health, a new health-focused version of its chatbot, just one day after a lawsuit in San Francisco alleged that ChatGPT’s medical guidance nearly led to a man’s death. The timing has drawn attention because the product launch arrived alongside fresh scrutiny of how people use AI tools for health questions.
According to the allegation highlighted in the report, Scott Winters experienced dizzy spells but chose not to see a doctor after consulting ChatGPT. The lawsuit claims the chatbot’s response discouraged him from seeking immediate medical care, turning a routine AI interaction into the center of a serious safety dispute.
The release of ChatGPT Health suggests OpenAI is continuing to expand its role in consumer health information, even as concerns grow about the limits of chatbot advice in medical situations. AI tools can summarize symptoms and provide general suggestions, but cases like this underscore the risks when users treat chatbot responses as a substitute for professional diagnosis or emergency care.
The overlap between the lawsuit and the launch is likely to intensify debate around OpenAI’s safeguards, product design and health-related disclaimers. As AI companies push further into sensitive areas such as medicine, questions about reliability, user trust and responsibility are becoming harder to separate from the technology itself.
